Status:
COMPLETED
The Effect of Fetal Gender on Maternal Substance Abuse Treatment
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Drug Dependence
Pregnancy
Eligibility:
FEMALE
Brief Summary
Previous studies by this team of investigators has determined that male infants are more likely to display more severe neonatal abstinence syndrome (NAS) as a result of maternal opioid use during preg...
Eligibility Criteria
Inclusion
- All CAP clients who either experience a pregnancy loss, or deliver an infant while in treatment at CAP between the years 7/1/03 and 6/30/08
Exclusion
- All CAP clients who depart CAP treatment prior to pregnancy loss or birth during that time period
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT00882648
Start Date
April 1 2009
End Date
September 1 2010
Last Update
February 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Center for Addiction and Pregnancy
Baltimore, Maryland, United States, 21224